SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vanta Bioscience gets order worth Rs 57 lakh

02 Dec 2023 Evaluate

Vanta Bioscience has received an order of Rs 57 lakh from a renowned Singapore Company to carry out GLP Studies which includes Bacterial Reverse Mutation assay, oral toxicity study and in vitro tests and other studies.

The said studies will be carried out by the company from its state of art research facility at Gummidipundi, Chennai. The turnaround time of the company for the project will be 26 weeks from receipt of requisite test items and/or such extended period as mutually agreed.

Vanta Bioscience is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.


Vanta Bioscience Share Price

18.19 -0.01 (-0.05%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 443.50
Indegene 487.75
CMS Info Systems 312.95
JITF Infralogistics 324.65
Sagility 42.24
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×